Fundraising Fox
🦊/People
Sign in

Jill Carroll

Investor

Operating Partner at SR One Capital Management · Board director at Airnexis Therapeutics Inc · Board director at Odyssey Therapeutics · Board director at Nkarta, Inc.

East Coast (US)

Find your path to Jill

213 people in our graph share verified history with Jill — schools, employers, funds. One of them is your warm intro.

Freya Svedberg-KeatingunlockedJill: together at SR One Capital Management (2023)
×5Jill: together at Duke University
×3Jill: together at Johns Hopkins University
×2Jill: together at SR One Capital Management

About

Jill Carroll is an Operating Partner at SR One, which she first joined in 2011, and manages several of the firm's investments. She holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University. Before SR One, she worked in strategy consulting and biotech corporate development, including at Dynavax Technologies.

Contact· self-published, not guessed

Invests in

Biotech

Board director at Airnexis Therapeutics Inc

Intro paths

→

In turn, Jill can intro founders to Airnexis Therapeutics Inc's investors below.

Airnexis Therapeutics Inc's investors · 1

SR One Capital ManagementRedwood City · since 2026

Board director at Odyssey Therapeutics

Intro paths

→

In turn, Jill can intro founders to Odyssey Therapeutics's investors below.

Odyssey Therapeutics's investors · 13

Activant CapitalNew York · $100K – $50M checksAscenta CapitalWilmington · since 2023Balderton CapitalLondon · $5M – $50M checksCatalio Capital Management, LPNew YorkDimension CapitalSan Francisco · $1M – $10M checks · since 2025Foresite CapitalWest HollywoodGlobal BioAccess FundNew York · $10M checksGreatPoint VenturesSan Francisco · $250K – $20M checksJeito CapitalParis · since 2025Lightspeed Venture PartnersMenlo Park · $1.7M – $87M checksOrbiMedNew York · $1M – $75M checksSanofi VenturesCambridge · $5M checksSR One Capital ManagementRedwood City · since 2025

Co-founders at Odyssey Therapeutics

GDGary D Glick
Gary D GlickExecutive Officer, Director

Board director at Nkarta, Inc.

Intro paths

→

In turn, Jill can intro founders to Nkarta, Inc.'s investors below.

Nkarta, Inc.'s investors · 8

Amgen VenturesThousand Oaks · $1M – $3M checksLogosSan FranciscoNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2019Norwest Venture PartnersMenlo Park · $10M – $30M checks · since 2019Novo HoldingsCopenhagen · $1.1M – $54M checksRA CapitalBostonSamsara BioCapitalPalo Alto · since 2019SR One Capital ManagementRedwood City · since 2019

Experience

  1. SR One Capital ManagementPartnercurrent2011 — present
  2. SR One Capital ManagementPrincipal2011
  3. Limerick BiopharmaVP, Corporate Development2010 — 2011
  4. Dynavax TechnologiesSr Director, Strategic Planning & Corporate Development2004 — 2010
  5. Clearview ProjectsDirector, Market Analysis2001 — 2004
  6. Mercer Management ConsultingConsultant1999 — 2001

Deals · 1

Odyssey TherapeuticsBoard seat

via SR One Capital Management · filed Dec 2025 · $214M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

92BioAirNexisArcellx (ACLX)Avalyn (AVLN)HotSpotOdysseyPoplar

Sources: SEC Form D filings · the firm's website.

Colleagues at SR One Capital Management

Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management

Network1

Deborah Harland
Partner at SR One Capital Management

Investors connected to Jill in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jill Carroll?
Jill Carroll is an Operating Partner at SR One, which she first joined in 2011, and manages several of the firm's investments. She holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University. Before SR One, she worked in strategy consulting and biotech corporate development, including at Dynavax Technologies.
Where does Jill Carroll work?
Jill Carroll is Operating Partner at SR One Capital Management and Board director at Airnexis Therapeutics Inc and Board director at Odyssey Therapeutics and Board director at Nkarta, Inc..
What does Jill Carroll invest in?
Jill Carroll invests in Biotech.
What boards does Jill Carroll sit on?
Jill Carroll holds tracked board seats at Odyssey Therapeutics.
What companies has Jill Carroll invested in?
Investments tracked here include 92Bio, AirNexis, Arcellx (ACLX), Avalyn (AVLN), HotSpot, Odyssey, Poplar.
Where did Jill Carroll go to school?
Jill Carroll studied at Johns Hopkins University (MS, Biochemistry); Duke University (Bachelor's degree, Chemistry).

Same school

Shared employers